ANX105
/ Annexon Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 19, 2024
Single Ascending Dose Study of ANX105
(clinicaltrials.gov)
- P1 | N=23 | Completed | Sponsor: Annexon, Inc. | Recruiting ➔ Completed | N=48 ➔ 23
Enrollment change • Trial completion
March 21, 2022
Single Ascending Dose Study of ANX105
(clinicaltrials.gov)
- P1 | N=48 | Recruiting | Sponsor: Annexon, Inc.
New P1 trial
1 to 2
Of
2
Go to page
1